Koers Lion Biotechnologies Inc OTC Bulletin Board
Aandelen
LBIO
US53619R1023
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- USD | - |
Omzet 2024 * | 161 mln. 150 mln. | Omzet 2025 * | 413 mln. 384 mln. | Marktkapitalisatie | 3,81 mld. 3,54 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -352 mln. -327 mln. | Nettowinst (verlies) 2025 * | -245 mln. -228 mln. | EV/omzet 2024 * | 22,8 x |
Nettoliquiditeiten 2024 * | 133 mln. 124 mln. | Nettoliquiditeiten 2025 * | 251 mln. 233 mln. | EV/omzet 2025 * | 8,63 x |
K/w-verhouding 2024 * |
-10,5
x | K/w-verhouding 2025 * |
-18,9
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 92,92% |
Recentste transcriptie over Lion Biotechnologies Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Frederick Vogt
CEO | Chief Executive Officer | 50 | 30-09-16 |
Director of Finance/CFO | 51 | 14-12-20 | |
Brian Shew
CTO | Chief Tech/Sci/R&D Officer | - | 01-07-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Merrill McPeak
BRD | Director/Board Member | 88 | 20-07-11 |
Director/Board Member | 56 | 07-06-16 | |
Michael Weiser
BRD | Director/Board Member | 61 | 15-03-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-16,10% | 11,41 mld. | |
-30,20% | 2,3 mld. | |
-14,31% | 2,16 mld. | |
-26,03% | 1,56 mld. | |
+36,95% | 1,19 mld. | |
-2,40% | 760 mln. | |
-19,00% | 506 mln. | |
-38,57% | 444 mln. | |
+13,72% | 339 mln. |
- Beurs
- Aandelen
- Koers IOVA
- Koers LBIO